CRISPR GUIDE SELECTION

Photoselective non-invasive targeted genomic and epigenomic sequencing of spatially-defined cells or subcellular regions

METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION THROUGH SINGLE-STEP MULTIPLE TARGETING

IMMUNE CELLS HAVING CO-EXPRESSED SHRNAS AND LOGIC GATE SYSTEMS

TARGETED GENE EDITING CONSTRUCTS AND METHODS OF USING THE SAME

COMPOSITIONS AND METHODS FOR IDENTIFYING AND INHIBITING A PAN-CANCER CELLULAR TRANSITION OF ADIPOSE-DERIVED STROMAL CELLS

PROTECTIVE ELEMENTS FOR NUCLEIC ACID SYNTHETIC BIOLOGY

CRISPR METHODS FOR TREATING CANCERS

COMPOSITIONS AND METHODS FOR TREATING HEMOGLOBINOPATHIES

NOVEL CRISPR-CAS SYSTEMS AND USES THEREOF

Method to engineer transplantable human tissues

EXOSOME COMPRISING STABILIZED RNA THERAPEUTICS

Compositions and methods for organ specific delivery of nucleic acids

LINKED TARGET CAPTURE

Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction

Oleic acid-enriched plant body having genetically modified FAD2 and production method thereof

GENE EDITING IN DIVERSE BACTERIA

COMPOSITIONS AND METHODS FOR CD33 MODIFICATION

COMPOSITIONS AND METHODS FOR EDITING BETA-GLOBIN FOR TREATMENT OF HEMAGLOBINOPATHIES

METHOD FOR AMPLIFYING AND DETECTING RIBONUCLEIC ACID (RNA) FRAGMENTS

DNA-CUTTING AGENT BASED ON CAS9 PROTEIN FROM THE BACTERIUM PASTEURELLA PNEUMOTROPICA

SINGLE BASE SUBSTITUTION PROTEIN, AND COMPOSITION COMPRISING SAME

CELLS FOR ENHANCED PRODUCTION OF ADENO-ASSOCIATED VIRUS

CLEAVING PRE-FUSION STATE SARS-COV-2 SPIKE PROTEIN

Methods for efficient delivery of therapeutic molecules in vitro and in vivo

ANTIBACTERIAL AGENTS & METHODS

GENE KNOCK-OUTS TO IMPROVE T CELL FUNCTION

Pharmaceutical composition for topical wound treatment

ENGINEERED CASX SYSTEMS

Abiotic stress tolerant plants and methods

PRODUCTION OF dsRNA IN PLANT CELLS FOR PEST PROTECTION VIA GENE SILENCING

PROTEIN TRANSLATIONAL CONTROL

TARGETED THERAPY

NON-CLASS I MULTI-COMPONENT NUCLEIC ACID TARGETING SYSTEMS

COMPOSITIONS AND METHODS FOR HOMOLOGY DIRECTED REPAIR

NUCLEOBASE EDITORS AND USES THEREOF

Targeting Nrip1 to alleviate metabolic disease

ENZYMES WITH RUVC DOMAINS

SYNTHESIS OF TRANSCRIPTS USING VSW-3 RNA POLYMERASE

Gene-regulating compositions and methods for improved immunotherapy

EXTRACELLULAR MATRIX-PRODUCING COMPOSITION USING MAST4 GENE AND PREPARATION METHOD THEREFOR

CELL PERMEABLE PROTEINS FOR GENOME ENGINEERING

Sequence specific antimicrobials

Sequence specific antimicrobials

Sequence specific antimicrobials

Universal donor cells

CELLS EXPRESSING A CHIMERIC RECEPTOR FROM A MODIFIED CD247 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS

Method and composition for sorting out of cell comprising a modified gene

SYSTEM AND METHODS FOR GENERATING DYNAMIC MATERIALS HAVING ARTIFICIAL METABOLISM

AAV DELIVERY OF NUCLEOBASE EDITORS

Abiotic stress tolerant plants and methods

METHODS FOR MAPPING PERSONALIZED TRANSLATOME

Variant CAS12 proteins with improved DNA cleavage selectivity and methods of use

MAD NUCLEASES

Nucleic acid-guided nickases

NOVEL OMNI CRISPR NUCLEASES

Thermostable CAS9 nucleases

CRISPR-Cas complex

MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES

MODULATION OF EXPRESSION OF GENES RELATED TO T CELL EXHAUSTION

IMAGING-BASED POOLED CRISPR SCREENING

USING SYNTHETIC LIXIVIANT BIOLOGY FOR THE RECOVERY OF PRECIOUS AND TOXIC METALS FROM ANTHROPOGENIC SOURCES

NON-DISRUPTIVE GENE TARGETING

PROTEIN TRANSLATIONAL CONTROL

SYSTEM FOR GENOME EDITING

POLYVALENT GUIDE RNAS FOR CRISPR ANTIVIRALS

TARGET-SPECIFIC CRISPR MUTANT

ENGINEERED CAS9 WITH BROADENED DNA TARGETING RANGE

Universal donor cells

LONG-LASTING ANALGESIA VIA TARGETED IN VIVO EPIGENETIC REPRESSION

CRISPR nuclease

COMPOSITIONS AND METHODS FOR CRISPR/CAS9 KNOCK-OUT OF CD33 IN HUMAN HEMATOPOIETIC STEM / PROGENITOR CELLS FOR ALLOGENIC TRANSPLANTATION IN PATIENTS WITH RELAPSED - REFRACTORY ACUTE MYELOID LEUKEMIA

Automated instrumentation for production of T-cell receptor peptide libraries

Automated cell processing methods, modules, instruments, and systems

Crispr enzymes and systems

Nucleic acid-guided nucleases

REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)

DELIVERY OF CRISPR/MCAS9 THROUGH EXTRACELLULAR VESICLES FOR GENOME EDITING

Curing for recursive nucleic acid-guided cell editing

Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated editing of HBB

CHEMICALLY MODIFIED GUIDE RNAS FOR CRISPR/CAS-MEDIATED GENE CORRECTION

Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation

SIMULTANEOUS MULTIPLEX GENOME EDITING IN YEAST

Combination chemotherapy for the treatment of cancer

OPTIMIZATION OF ENGINEERED MEGANUCLEASES FOR RECOGNITION SEQUENCES

CRISPR/CAS-BASED GENOME EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION

ENGINEERED SSDNASE-FREE CRISPR ENDONUCLEASES

Lipid-encapsulated dual-cleaving endonuclease for DNA and gene editing

METHODS OF ACHIEVING HIGH SPECIFICITY OF GENOME EDITING

ATTENUATION OF BACTERIAL INFECTION

NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF

ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A

METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF HEMOGLOBINOPATHY

Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy

HEMOPHILIA B RAT MODEL

Inbred watermelon line WDL0090

COMPOSITIONS AND METHODS FOR NUCLEOTIDE MODIFICATION-BASED DEPLETION

IMPROVEMENTS RELATING TO CELL TRANSFECTION

AAV-CAS13D VECTORS AND USES THEREOF

ARGONAUTE PROTEINS FROM PROKARYOTES AND APPLICATIONS THEREOF

Haploid inducer line for accelerated genome editing

SYNTHETIC SELF-REPLICATING RNA VECTORS ENCODING CRISPR PROTEINS AND USES THEREOF

METHODS AND COMPOSITIONS FOR CORRECTED ABERRANT SPLICE SITES

Compositions and Methods for Treatment of Disorders Associated with Repetitive DNA

NOVEL Cas ENZYME AND SYSTEM, AND USE THEREOF

Cas9 fusion molecules, gene editing systems, and methods of use thereof

TCRα homing endonuclease variants

DNA-BINDING DOMAIN TRANSACTIVATORS AND USES THEREOF

AAV VECTOR-MEDIATED DELETION OF LARGE MUTATIONAL HOTSPOT FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

CELLS EXPRESSING A RECOMBINANT RECEPTOR FROM A MODIFIED TGFBR2 LOCUS, RELATED POLYNUCLEOTIDES AND METHODS

Synthetic Lethality Screening Platform for Cells Undergoing ALT

Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells

Genome editing system

Visualized Screening Method for Aspergillus Recombinant Strains with Multigene Editing

Methods for integrating a donor DNA sequence into the genome of bacillus using linear recombinant DNA constructs and compositions thereof

GENERATION OF CHIMERIC ANTIGEN RECEPTOR (CAR)-PRIMARY NK CELLS FOR CANCER IMMUNOTHERAPY USING A COMBINATION OF CAS9/RNP AND AAV VIRUSES

Gene therapeutics for fibrodysplasia ossificans progressiva

RNA-guided human genome engineering

Methods for increasing observed editing in bacteria

ENGINEERED EXOSOMES FOR TARGETED DELIVERY

CRISPR/CAS-BASED BASE EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION

CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2

HIGHLY MULTIPLEXED BASE EDITING

DEEP MUTATIONAL EVOLUTION OF BIOMOLECULES

Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells

CRISPR-associated (Cas) protein

TYPE VII CRISPR PROTEINS AND SYSTEMS

Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling

Engineered Cas9 nucleases

PDCD-1 HOMING ENDONUCLEASE VARIANTS

FUSION PROTEIN FOR ENHANCING GENE EDITING AND USE THEREOF

FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE

TARGETED DISRUPTION OF THE MHC CELL RECEPTOR

METHOD FOR DETECTING TARGET NUCLEIC ACID AND KIT

PROGRAMMABLE DNA-GUIDED ARTIFICIAL RESTRICTION ENZYMES

SYSTEM

Recombinant type I CRISPR-Cas system and uses thereof for killing target cells

Homology dependent repair genome editing

PLANT EXPLANT TRANSFORMATION

AMINOACYL-TRNA SYNTHETASE FOR EFFICIENTLY INTRODUCING LYSINE DERIVATIVE IN PROTEIN

ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE

T:A TO A:T BASE EDITING THROUGH ADENOSINE METHYLATION

COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF CAS NUCLEASES

Engineered CRISPR-Cas9 nucleases with altered PAM specificity

IMPROVED PROCESS FOR DNA INTEGRATION USING RNA-GUIDED ENDONUCLEASES

POLYPEPTIDES HAVING BETA-GLUCANASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF IN CLEANING AND DETERGENT COMPOSITIONS

T CELL RECEPTORS AND METHODS OF USE THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

GENOME EDITED PRIMARY B CELL AND METHODS OF MAKING AND USING

SYNTHETIC LIPIDS FOR MRNA DELIVERY

Genetically modified rat models for severe combined immunodeficiency (SCID)

CELL-FREE PRODUCTION OF RIBONUCLEIC ACID

NOVEL NUCLEIC ACID MODIFIERS

COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING

METHOD FOR INDUCING TARGETED MEIOTIC RECOMBINATIONS

Nucleic acid-guided nucleases

USE OF SOYBEAN PROTEIN KINASE GENE GMSTK_IRAK

Methods For Polynucleotide Integration Into The Genome Of Bacillus Using Dual Circular Recombinant DNA Constructs And Compositions Thereof

Applications of Streptococcus-derived Cas9 nucleases on minimal Adenine-rich PAM targets

HIGH THROUGHPUT GENE EDITING SYSTEM AND METHOD

DUPLEX-SPECIFIC NUCLEASE DEPLETION FOR PURIFICATION OF NUCLEIC ACID SAMPLES

CPF1 COMPLEXES WITH REDUCED INDEL ACTIVITY

MITOCHONDRIAL GENOME EDITING METHODS

Engineering of DNASE enzymes for manufacturing and therapy

Modulating human Cas9-specific host immune response

METHODS, USES & COMPOSITIONS

Compositions and methods for analyzing DNA using partitioning and base conversion

ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS

CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS

Systems, methods, and compositions for site-specific genetic engineering using programmable addition via site-specific targeting elements (paste)

NOVEL NUCLEIC ACID MODIFIERS

MINIMAL PROMOTER

SYSTEM AND METHOD FOR LIGHT-REGULATED OLIGOMERIZATION AND PHASE SEPARATION OF FOLDED DOMAINS AND RNA GRANULE-ASSOCIATED PROTEIN DOMAINS FOR DRUG- BASED SCREENING APPLICATIONS

INTRODUCING SILENCING ACTIVITY TO DYSFUNCTIONAL RNA MOLECULES AND MODIFYING THEIR SPECIFICITY AGAINST A GENE OF INTEREST

METHODS FOR SCREENING FOR CANCER TARGETS

Compositions and Methods for Preparing Nucleic Acid Sequencing Libraries Using CRISPR/CAS9 Immobilized on a Solid Support

METHODS AND COMPOSITIONS FOR ASSESSING PROTEIN FUNCTION

HIGH-PRECISION BASE EDITORS

CAS9 VARIANTS WITH ENHANCED SPECIFICITY

NEW ENGINEERED HIGH FIDELITY CAS9

MICROGLIAL PROGENITORS FOR REGENERATION OF FUNCTIONAL MICROGLIA IN THE CENTRAL NERVOUS SYSTEM AND THERAPEUTICS USES THEREOF

NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

T CELL RECEPTORS AND METHODS OF USE THEREOF

METHODS FOR TARGETED DEPLETION OF NUCLEIC ACIDS

COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF ALLELES

IMPROVED PROCESS FOR INTEGRATION OF DNA CONSTRUCTS USING RNA-GUIDED ENDONUCLEASES

CELL PENETRATING TRANSPOSASE

Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery

Artificial nucleases comprising engineered cleavage half-domains

CAS12a GUIDE RNA MOLECULES AND USES THEREOF

RNA-TARGETING CAS ENZYMES

POLYPEPTIDES USEFUL FOR GENE EDITING AND METHODS OF USE

SYSTEMS, METHODS, AND COMPOSITIONS FOR SITE-SPECIFIC GENETIC ENGINEERING USING PROGRAMMABLE ADDITION VIA SITE-SPECIFIC TARGETING ELEMENTS (PASTE)

HTP GENOMIC ENGINEERING PLATFORM FOR IMPROVING FUNGAL STRAINS

BARCODED CLONAL TRACKING OF GENE TARGETING IN CELLS

Affinity tag for recombination protein recruitment

TRANSCRIPTIONAL ROADBLOCKS FOR GENE EDITING AND METHODS OF USING THE SAME

Engineered CRISPR-Cas9 nucleases with altered PAM specificity

NOVEL HIGH FIDELITY RNA-PROGRAMMABLE ENDONUCLEASE SYSTEMS AND USES THEREOF

A Method of Altering a Differentiation Status of a Cell

Methods of treating and diagnosing epilepsy

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

Sequence specific antimicrobials

COMPOSITIONS AND METHODS FOR MODULATING CGRP SIGNALING TO REGULATE INTESTINAL INNATE LYMPHOID CELLS

MODIFIED NATURAL KILLER (NK) CELLS FOR IMMUNOTHERAPY

ISOLATION AND DETECTION OF EXOSOME-ASSOCIATED MICROBIOME FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES

METHOD FOR MULTIPLEX NUCLEIC ACID DETECTION BASED ON CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT

ISOTHERMAL AMPLIFICATION AND AMBIENT VISUALIZATION IN A SINGLE TUBE FOR THE DETECTION OF SARS-COV-2 USING LOOP-MEDIATED AMPLIFICATION AND CRISPR TECHNOLOGY

NOVEL CLASS 2 CRISPR-CAS RNA-GUIDED ENDONUCLEASES

CRISPR SYSTEMS WITH ENGINEERED DUAL GUIDE NUCLEIC ACIDS

DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF STAT1

NUCLEOBASE EDITORS HAVING REDUCED OFF-TARGET DEAMINATION AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE TARGET SEQUENCE

Targeted In Vivo Genome Modification

GENOME-EDITED BIRDS

recombinant phages, method of production and uses thereof

Phage-derived particles for in situ delivery of DNA payload into population

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

Methods for improving the health of porcine species by targeted inactivation of CD163

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING USHER SYNDROME AND RETINITIS PIGMENTOSA

PLANT DNA METHYLTRANSFERASES AND USES THEREOF

CLASS 2 CRISPR-CAS RNA-GUIDED ENDONUCLEASES

Small Molecules for Dual Function Positron Emission Tomography (PET) and Cell Suicide Switches

Derivatisation of Insulin with Polysaccharides

MODIFIED IMMUNE CELLS HAVING ENHANCED ANTI-NEOPLASIA ACTIVITY AND IMMUNOSUPPRESSION RESISTANCE

CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP)

Compositions and methods for organ specific delivery of nucleic acids

SYSTEMS AND METHODS FOR ULTRA-SPECIFIC AND ULTRA-SENSITIVE NUCLEIC ACID DETECTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

POLIOVIRUS RECEPTOR (PVR/CD155) KNOCKOUT CELLS DERIVED FROM RD (HUMAN RHABDOMYOSARCOMA) CELL LINE BY CRISPR

CONTROLLABLE GENOME EDITING SYSTEM

Compositions and Methods for Improving Base Editing

FUSION PROTEINS AND FUSION RIBONUCLEIC ACIDS FOR TRACKING AND MANIPULATING CELLULAR RNA

Safe harbor loci

NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF

GRNA TARGETING MIR-29B, AAV8-CRISPER/CAS9 SYSTEM AND USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A

MATERIALS AND METHODS FOR BONE MARROW TRANSPLANTATION

MODIFIED CELLS AND METHODS OF THERAPY

SINGLE-STRANDED NUCLEIC ACID FOR REAL-TIME DETECTION OF GENETIC VARIATION OF SINGLE TARGET GENE AND DETECTION METHOD USING THE SAME

IN-SITU SPATIAL TRANSCRIPTOMICS

Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

CRISPR enabled multiplexed genome engineering

GENOME EDITING TO INCREASE SEED PROTEIN CONTENT

HIGH-EFFICACY CRISPRI SYSTEM AND STRONG SYNTHETIC PROMOTERS FOR ALPHAPROTEOBACTERIA AND GAMMAPROTEOBACTERIA

CRISPR-cas9 SYSTEM AND USES THEREOF

TYPE VI-E AND TYPE VI-F CRISPR-CAS SYSTEM AND USES THEREOF

METHOD FOR ENGINEERING A PROTEIN

PROGRAMMABLE NUCLEASE IMPROVEMENTS AND COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION AND DETECTION

VIRUS THERAPY

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED TRANSFERRIN GENE

Cas variants for gene editing

HOMING ENDONUCLEASE VARIANTS

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

Male sterile crop mutated on Ty-5 gene

METHODS AND COMPOSITION FOR TRANSFERRING T-DNA INTO A PLANT

GENE KNOCK-IN METHOD, GENE KNOCK-IN CELL FABRICATION METHOD, GENE KNOCK-IN CELL, MALIGNANT TRANSFORMATION RISK EVALUATION METHOD, CANCER CELL PRODUCTION METHOD, AND KIT FOR USE IN THESE

INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS

METHODS AND COMPOSITIONS FOR ALLELE SPECIFIC GENE EDITING

Optimized binuclease fusions and methods

ENGINEERED PROTEINS AND METHODS OF USE THEREOF

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

Instruments, modules, and methods for improved detection of edited sequences in live cells

Chimeric receptor binding proteins for use in bacterial delivery vehicles

Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells

SOLUTION-PHASE, TRANS-ACTIVATED REPORTER SYSTEMS FOR USE IN CRISPR-BASED NUCLEIC ACID SEQUENCE DETECTIONS

Methods, compositions and kits for increasing genome editing efficiency

METHOD FOR INCREASING CANNABIS YIELD VIA GENE EDITING

CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY

DUX4 RNA Silencing Using RNA Targeting CRISPR-CAS13b

METHODS AND KITS FOR GENERATING AND SELECTING A VARIANT OF A BINDING PROTEIN WITH INCREASED BINDING AFFINITY AND/OR SPECIFICITY

Modified DNase and uses thereof

TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY

METHODS OF DETECTING MICROBIAL CONTENT IN CANNABIS

CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF RIBOSOMAL PROTEIN S19 (RPS19) GENE

NOVEL NUCLEIC ACID MODIFIERS

ANTI-CRISPR-MEDIATED CONTROL OF GENOME EDITING AND SYNTHETIC CIRCUITS IN EUKARYOTIC CELLS

SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE

NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS

NEOANTIGENS CREATED BY ABERRANT-INDUCED SPLICING AND USES THEREOF IN ENHANCING IMMUNOTHERAPY

NUCLEOBASE EDITORS HAVING REDUCED NON-TARGET DEAMINATION AND ASSAYS FOR CHARACTERIZING NUCLEOBASE EDITORS

Engineered enzyme

Compositions and methods for epigenome editing

PHARMACEUTICAL COMPOSITION OR FOOD COMPOSITION, AND METHOD FOR ASSESSING EFFECT OF ACTIVE INGREDIENT IN VIVO

Liposomal Nanoparticle

DEVICES FOR CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS

DETECTION METHOD FOR A TARGET NUCLEIC ACID AND KIT

Attb cell line, transgenic cell lines derived therefrom, and methods of making the same

RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci

VIRAL VECTOR COMBINING GENE THERAPY AND GENOME EDITING APPROACHES FOR GENE THERAPY OF GENETIC DISORDERS

RNA VIRAL RNA MOLECULE FOR GENE EDITING

METHOD FOR PRODUCING COMPOUND WITH MODIFIED MOTHER NUCLEUS

GENETIC CONSTRUCT

A METHOD FOR ASSEMBLING CIRCULAR AND LINEAR DNA MOLECULES IN AN ORDERED MANNER